Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Killing often spoken of as natural hellip; the cryptic orphan killer cells.

Immunology today

Koren H, Herberman R.
PMID: 25291469
Immunol Today. 1983 Apr;4(4):97-9. doi: 10.1016/0167-5699(83)90012-9.

No abstract available.

Cite
Koren H, Herberman R. Killing often spoken of as natural hellip; the cryptic orphan killer cells. Immunol Today. 1983;4(4):97-9doi: 10.1016/0167-5699(83)90012-9.
Koren, H., & Herberman, R. (1983). Killing often spoken of as natural hellip; the cryptic orphan killer cells. Immunology today, 4(4), 97-9. https://doi.org/10.1016/0167-5699(83)90012-9
Koren, H, and Herberman, R. "Killing often spoken of as natural hellip; the cryptic orphan killer cells." Immunology today vol. 4,4 (1983): 97-9. doi: https://doi.org/10.1016/0167-5699(83)90012-9
Koren H, Herberman R. Killing often spoken of as natural hellip; the cryptic orphan killer cells. Immunol Today. 1983 Apr;4(4):97-9. doi: 10.1016/0167-5699(83)90012-9. PMID: 25291469.
Copy Download .nbib Format: NLM
'Immune surveillance' without immunogenicity.

Immunology today

Grossman Z, Herberman RB.
PMID: 25289999
Immunol Today. 1986 May;7(5):128-31. doi: 10.1016/0167-5699(86)90075-7.

The hypothesis of immune surveillance against cancer is based on two premises; (1) that transformed and normal cells generally have different antigenic qualities, and (2) that the immune system responds to the antigenically modified cells in essentially the same...

Cite
Grossman Z, Herberman RB. 'Immune surveillance' without immunogenicity. Immunol Today. 1986;7(5):128-31doi: 10.1016/0167-5699(86)90075-7.
Grossman, Z., & Herberman, R. B. (1986). 'Immune surveillance' without immunogenicity. Immunology today, 7(5), 128-31. https://doi.org/10.1016/0167-5699(86)90075-7
Grossman, Z, and Herberman, R B. "'Immune surveillance' without immunogenicity." Immunology today vol. 7,5 (1986): 128-31. doi: https://doi.org/10.1016/0167-5699(86)90075-7
Grossman Z, Herberman RB. 'Immune surveillance' without immunogenicity. Immunol Today. 1986 May;7(5):128-31. doi: 10.1016/0167-5699(86)90075-7. PMID: 25289999.
Copy Download .nbib Format: NLM
Andrei Sulica, MD, 1938-2000.

Natural immunity

Herberman RB.
PMID: 11093062
Nat Immun. 1998 Sep;16(5):176-177. doi: 10.1159/000069443.

Copyright 2000 S. Karger AG, Basel

Cite
Herberman RB. Andrei Sulica, MD, 1938-2000. Nat Immun. 1998;16(5):176-177doi: 10.1159/000069443.
Herberman, R. B. (1998). Andrei Sulica, MD, 1938-2000. Natural immunity, 16(5), 176-177. https://doi.org/10.1159/000069443
Herberman. "Andrei Sulica, MD, 1938-2000." Natural immunity vol. 16,5 (1998): 176-177. doi: https://doi.org/10.1159/000069443
Herberman RB. Andrei Sulica, MD, 1938-2000. Nat Immun. 1998 Sep;16(5):176-177. doi: 10.1159/000069443. PMID: 11093062.
Copy Download .nbib Format: NLM
Managing stress and managing illness: Survival and quality of life in chronic disease.

Journal of clinical psychology in medical settings

Baum A, Herberman H, Cohen L.
PMID: 24226413
J Clin Psychol Med Settings. 1995 Dec;2(4):309-33. doi: 10.1007/BF01991680.

Interest has been steadily building in the impact of stress on psychological and physiological functioning, in particular on immune system responses, furthering the concept of a strong connection between the mind and the body. Implications for prevention of disease...

Cite
Baum A, Herberman H, Cohen L. Managing stress and managing illness: Survival and quality of life in chronic disease. J Clin Psychol Med Settings. 1995;2(4):309-33doi: 10.1007/BF01991680.
Baum, A., Herberman, H., & Cohen, L. (1995). Managing stress and managing illness: Survival and quality of life in chronic disease. Journal of clinical psychology in medical settings, 2(4), 309-33. https://doi.org/10.1007/BF01991680
Baum, A, et al. "Managing stress and managing illness: Survival and quality of life in chronic disease." Journal of clinical psychology in medical settings vol. 2,4 (1995): 309-33. doi: https://doi.org/10.1007/BF01991680
Baum A, Herberman H, Cohen L. Managing stress and managing illness: Survival and quality of life in chronic disease. J Clin Psychol Med Settings. 1995 Dec;2(4):309-33. doi: 10.1007/BF01991680. PMID: 24226413.
Copy Download .nbib Format: NLM
Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

Immunology today

Herberman RB, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R, Golub S, Lanier LL, Phillips JH, Riccardi C, Ritz J, Santoni A, Schmidt RE, Uchida A.
PMID: 25290217
Immunol Today. 1987;8(6):178-81. doi: 10.1016/0167-5699(87)90035-1.

Leukocytes in blood and spleen can be activated by interleukin 2 (IL-2) to become cytotoxic to certain tumor cell lines in vitro. Recent evidence suggests that such lymphokine-activated killer (LAK) cells can bring about the regression of solid tumors...

Cite
Herberman RB, Hiserodt J, Vujanovic N, et al. Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today. 1987;8(6):178-81doi: 10.1016/0167-5699(87)90035-1.
Herberman, R. B., Hiserodt, J., Vujanovic, N., Balch, C., Lotzova, E., Bolhuis, R., Golub, S., Lanier, L. L., Phillips, J. H., Riccardi, C., Ritz, J., Santoni, A., Schmidt, R. E., & Uchida, A. (1987). Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. Immunology today, 8(6), 178-81. https://doi.org/10.1016/0167-5699(87)90035-1
Herberman, R B, et al. "Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen." Immunology today vol. 8,6 (1987): 178-81. doi: https://doi.org/10.1016/0167-5699(87)90035-1
Herberman RB, Hiserodt J, Vujanovic N, Balch C, Lotzova E, Bolhuis R, Golub S, Lanier LL, Phillips JH, Riccardi C, Ritz J, Santoni A, Schmidt RE, Uchida A. Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. Immunol Today. 1987;8(6):178-81. doi: 10.1016/0167-5699(87)90035-1. PMID: 25290217.
Copy Download .nbib Format: NLM
Arleen Claire Levin 1945-1977.

Journal of the National Cancer Institute

Haberman RB, Deinhardt F.
PMID: 349167
J Natl Cancer Inst. 1978 Jun;60(6):1185-6.

No abstract available.

Cite
Haberman RB, Deinhardt F. Arleen Claire Levin 1945-1977. J Natl Cancer Inst. 1978;60(6):1185-6
Haberman, R. B., & Deinhardt, F. (1978). Arleen Claire Levin 1945-1977. Journal of the National Cancer Institute, 60(6), 1185-6.
Haberman, R B, and Deinhardt, F. "Arleen Claire Levin 1945-1977." Journal of the National Cancer Institute vol. 60,6 (1978): 1185-6.
Haberman RB, Deinhardt F. Arleen Claire Levin 1945-1977. J Natl Cancer Inst. 1978 Jun;60(6):1185-6. PMID: 349167.
Copy Download .nbib Format: NLM
Antitumor Functions of Natural Killer Cells and Control of Metastases.

Methods (San Diego, Calif.)

Vujanovic NL, Basse P, Herberman RB, Whiteside TL.
PMID: 8812692
Methods. 1996 Apr;9(2):394-408. doi: 10.1006/meth.1996.0044.

Natural killer (NK) cells have been recognized as effector cells responsible for the elimination of blood-borne metastases. Newer evidence suggests that NK cells play an important role in the control of solid tissue metastases. NK cells have the ability...

Cite
Vujanovic NL, Basse P, Herberman RB, et al. Antitumor Functions of Natural Killer Cells and Control of Metastases. Methods. 1996;9(2):394-408doi: 10.1006/meth.1996.0044.
Vujanovic, N. L., Basse, P., Herberman, R. B., & Whiteside, T. L. (1996). Antitumor Functions of Natural Killer Cells and Control of Metastases. Methods (San Diego, Calif.), 9(2), 394-408. https://doi.org/10.1006/meth.1996.0044
Vujanovic, et al. "Antitumor Functions of Natural Killer Cells and Control of Metastases." Methods (San Diego, Calif.) vol. 9,2 (1996): 394-408. doi: https://doi.org/10.1006/meth.1996.0044
Vujanovic NL, Basse P, Herberman RB, Whiteside TL. Antitumor Functions of Natural Killer Cells and Control of Metastases. Methods. 1996 Apr;9(2):394-408. doi: 10.1006/meth.1996.0044. PMID: 8812692.
Copy Download .nbib Format: NLM
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC).

Cancer informatics

Patel AA, Gilbertson JR, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU, Prichard J, Wilkerson M, Herberman RB, Becich MJ.
PMID: 19455246
Cancer Inform. 2007 Jun 08;3:255-74.

BACKGROUND: The Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC, http://www.pcabc.upmc.edu) is one of the first major project-based initiatives stemming from the Pennsylvania Cancer Alliance that was funded for four years by the Department of Health of the Commonwealth of Pennsylvania....

Cite
Patel AA, Gilbertson JR, Showe LC, et al. A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform. 2007;3:255-74
Patel, A. A., Gilbertson, J. R., Showe, L. C., London, J. W., Ross, E., Ochs, M. F., Carver, J., Lazarus, A., Parwani, A. V., Dhir, R., Beck, J. R., Liebman, M., Garcia, F. U., Prichard, J., Wilkerson, M., Herberman, R. B., Becich, M. J. (2007). A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer informatics, 3255-74.
Patel, Ashokkumar A, et al. "A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC)." Cancer informatics vol. 3 (2007): 255-74.
Patel AA, Gilbertson JR, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU, Prichard J, Wilkerson M, Herberman RB, Becich MJ. A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform. 2007 Jun 08;3:255-74. PMID: 19455246; PMCID: PMC2675833.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries